Svenja Ulferts

Svenja Ulferts

Auto-generated profile, based on publicly available information

Svenja Ulferts

Institute of Experimental and Clinical Pharmacology and Toxicology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Cell
Verified
Journal Article
Closed access
MBMehdi Bouhaddou
Mehdi Bouhaddou
DMDanish Memon
Danish Memon
BMBjoern Meyer
Bjoern Meyer
KWKris White
Kris White
VRVeronica V. Rezelj
Veronica V. Rezelj
NKNevan J. Krogan
Nevan J. Krogan

4 December 2020 in Science
Verified
Journal Article
Open access
PDF file
DGDavid E. Gordon
David E. Gordon
JHJoseph Hiatt
Joseph Hiatt
MBMehdi Bouhaddou
Mehdi Bouhaddou
VRVeronica V. Rezelj
Veronica V. Rezelj
SUSvenja Ulferts
Svenja Ulferts
HLHarris A. Lewin
Harris A. Lewin
How lethal coronaviruses engage hosts: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is closely related to the deadly coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Considerable efforts are focused on developing treatments, and therapies that work across coronaviruses would be particularly valuable. Shedding light on the host factors hijacked by the viruses, Gordon et al. mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host factors that either enhance or inhibit viral infection. For a subset of the interactions essential for the virus life cycle, the authors determined the cryo–electron microscopy structures and mined patient data to understand how targeting host factors may be relevant to clinical outcomes. Science , this issue p. eabe9403

4 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
SWSebastian Weigang
Sebastian Weigang
JFJonas Fuchs
Jonas Fuchs
GZGert Zimmer
Gert Zimmer
DSDaniel Schnepf
Daniel Schnepf
LKLisa Kern
Lisa Kern
GKGeorg Kochs
Georg Kochs
The origin of SARS-CoV-2 variants of concern remains unclear. Here, we test whether intra-host virus evolution during persistent infections could be a contributing factor by characterizing the long-term SARS-CoV-2 infection dynamics in an immunosuppressed kidney transplant recipient. Applying RT-qPCR and next-generation sequencing (NGS) of sequential respiratory specimens, we identify several mutations in the viral genome late in infection. We demonstrate that a late viral isolate exhibiting genome mutations similar to those found in variants of concern first identified in UK, South Africa, and Brazil, can escape neutralization by COVID-19 antisera. Moreover, infection of susceptible mice with this patient’s escape variant elicits protective immunity against re-infection with either the parental virus and the escape variant, as well as high neutralization titers against the alpha and beta SARS-CoV-2 variants, B.1.1.7 and B.1.351, demonstrating a considerable immune control against such variants of concern. Upon lowering immunosuppressive treatment, the patient generated spike-specific neutralizing antibodies and resolved the infection. Our results suggest that immunocompromised patients could be a source for the emergence of potentially harmful SARS-CoV-2 variants.

6 May 2019 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
EMEric Metzger
Eric Metzger
SWSheng Wang
Sheng Wang
SUSylvia Urban
Sylvia Urban
DWDominica Willmann
Dominica Willmann
ASAndreas Schmidt
Andreas Schmidt
RSRoland Schüle
Roland Schüle

15 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
CLChenyang Lan
Chenyang Lan
JKJuhyeong Kim
Juhyeong Kim
SUSvenja Ulferts
Svenja Ulferts
FAFernando Aprile-Garcia
Fernando Aprile-Garcia
SWSophie Weyrauch
Sophie Weyrauch
THThorsten Hugel
Thorsten Hugel
Our current understanding of biomolecular condensate formation is largely based on observing the final near-equilibrium condensate state. Despite expectations from classical nucleation theory, pre-critical protein clusters were recently shown to form under subsaturation conditions in vitro; if similar long-lived clusters comprising more than a few molecules are also present in cells, our understanding of the physical basis of biological phase separation may fundamentally change. Here, we combine fluorescence microscopy with photobleaching analysis to quantify the formation of clusters of NELF proteins in living, stressed cells. We categorise small and large clusters based on their dynamics and their response to p38 kinase inhibition. We find a broad distribution of pre-condensate cluster sizes and show that NELF protein cluster formation can be explained as non-classical nucleation with a surprisingly flat free-energy landscape for a wide range of sizes and an inhibition of condensation in unstressed cells.

1 January 2021 in Molecular Therapy
Verified
Journal Article
Open access
OSOliver Sommerfeld
Oliver Sommerfeld
AMAnna Medyukhina
Anna Medyukhina
SNSophie Neugebauer
Sophie Neugebauer
MGMohamed Ghait
Mohamed Ghait
SUSvenja Ulferts
Svenja Ulferts
Adrian Tibor PressAdrian Tibor Press
Adrian Tibor Press
Complement factor C5a was originally identified as a powerful promoter of inflammation through activation of the C5a receptor 1 (C5ar1). Recent evidence suggests involvement of C5a not only in pro- but also in anti-inflammatory signaling. The present study aims to unveil the role of C5ar1 as potential therapeutic target in a murine sepsis model. Our study discloses a significantly increased survival in models of mild to moderate but not severe sepsis of C5ar1-deficient mice. The decreased mortality of C5ar1-deficient mice is accompanied by improved pathogen clearance and largely preserved liver function. C5ar1-deficient mice exhibited a significantly increased production of the pro-inflammatory mediator interferon-γ (IFN-γ) and a decreased production of the anti-inflammatory cytokine interleukin-10 (IL-10). Together, these data uncover C5a signaling as a mediator of immunosuppressive processes during sepsis and describe the C5ar1 and related changes of the IFN-γ to IL-10 ratio as markers for the immunological (dys)function accompanying sepsis.